PINATO, David James
PINATO, David James
Dipartimento di Medicina Traslazionale
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
2022-01-01 Cortellini, A.; Barrichello, A. P. C.; Alessi, J. V.; Ricciuti, B.; Vaz, V. R.; Newsom-Davis, T.; Evans, J. S.; Lamberti, G.; Pecci, F.; Viola, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Awad, M. M.; Pinato, D. J.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
2021-01-01 Khaki, Ali Raza; Li, Ang; Diamantopoulos, Leonidas N; Miller, Natalie J; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Koshkin, Vadim; Park, Joseph; Alva, Ajjai; Bilen, Mehmet A; Stewart, Tyler; Santos, Victor; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yousef; Morales-Barrera, Rafael; Devitt, Michael; Nelson, Ariel; Hoimes, Christopher J; Shreck, Evan; Gartrell, Benjamin A; Sankin, Alex; Tripathi, Abhishek; Zakopoulou, Roubini; Bamias, Aristotelis; Rodriguez-Vida, Alejo; Drakaki, Alexandra; Liu, Sandy; Kumar, Vivek; Lythgoe, Mark P; Pinato, David J; Murgic, Jure; Fröbe, Ana; Joshi, Monika; Isaacsson Velho, Pedro; Hahn, Noah; Alonso Buznego, Lucia; Duran, Ignacio; Moses, Marcus; Barata, Pedro; Galsky, Matthew D; Sonpavde, Guru; Yu, Evan Y; Shankaran, Veena; Lyman, Gary H; Grivas, Petros
A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
2012-01-01 Pinato, D. J.; Stebbing, J.; Ishizuka, M.; Khan, S. A.; Wasan, H. S.; North, B. V.; Kubota, K.; Sharma, R.
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC
2023-01-01 Chen, M.; Lu, H.; Copley, S. J.; Han, Y.; Logan, A.; Viola, P.; Cortellini, A.; Pinato, D. J.; Power, D.; Aboagye, E. O.
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: The prognostic nutritional index (PNI)
2012-01-01 Pinato, D. J.; North, B. V.; Sharma, R.
A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers
2012-01-01 Libri, V.; Brown, A. P.; Gambarota, G.; Haddad, J.; Shields, G. S.; Dawes, H.; Pinato, D. J.; Hoffman, E.; Elliot, P. J.; Vlasuk, G. P.; Jacobson, E.; Wilkins, M. R.; Matthews, P. M.
Acceleration of interstitial lung disease induced by raltitrexed
2020-01-01 Howlett, S.; Aul, R.; Hill, M.; Pinato, D. J.
Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis
2021-01-01 Gudd, C. L. C.; Au, L.; Triantafyllou, E.; Shum, B.; Liu, T.; Nathwani, R.; Kumar, N.; Mukherjee, S.; Dhar, A.; Woollard, K. J.; Yone, Y.; Pinato, D. J.; Thursz, M. R.; Goldin, R. D.; Gore, M. E.; Larkin, J.; Khamri, W.; Antoniades, C. G.; Turajlic, S.; Possamai, L. A.
Advanced age influences the dynamic changes in circulating C-reactive protein following injury
2013-01-01 Pinato, D. J.; Bains, J.; Irkulla, S.; Pomroy, J.; Ujam, B.; Gaze, D.; Mendall, M. A.
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
2021-01-01 Demirtas, Coskun O; D'Alessio, Antonio; Rimassa, Lorenza; Sharma, Rohini; Pinato, David J
Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway
2014-01-01 Trousil, S.; Lee, P.; Pinato, D. J.; Ellis, J. K.; Dina, R.; Aboagye, E. O.; Keun, H. C.; Sharma, R.
An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: Correlation with tumour phenotype and survival outcomes
2014-01-01 Pinato, D. J.; Tan, T. M.; Toussi, S. T. K.; Ramachandran, R.; Martin, N.; Meeran, K.; Ngo, N.; Dina, R.; Sharma, R.
An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials
2014-01-01 Pinato, D. J.; Stavraka, C.; Flynn, M. J.; Forster, M. D.; O'Cathail, S. M.; Seckl, M. J.; Kristeleit, R. S.; Olmos, D.; Turnbull, S. J.; Blagden, S. P.
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
2012-01-01 Pinato, D. J.; Sharma, R.
An unexpected cause of pulmonary cannonball lesion
2014-01-01 Pinato, D. J.; Tan, W.; Gately, A.
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
2021-01-01 Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Elisa Onesti, Concetta; Harbeck, Nadia; Lüftner, Diana; Rottey, Sylvie; van Dam, Peter A.; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne C. G.; Cortes, Javier; Locci, Mariavittoria; Paris, Ida; Del Mastro, Lucia; De Placido, Sabino; Martín, Miguel; Jerusalem, Guy; Venturini, Sergio; Curigliano, Giuseppe; Generali, Daniele
Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters
2022-01-01 Cortellini, A.; Facchinetti, F.; Derosa, L.; Pinato, D. J.
Antibiotic therapy and outcome from immune-checkpoint inhibitors
2019-01-01 Pinato, D. J.; Gramenitskaya, D.; Altmann, D. M.; Boyton, R. J.; Mullish, B. H.; Marchesi, J. R.; Bower, M.
Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors
2023-01-01 Pinato, David J; Cortellini, Alessio
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients with Cancer - Reply
2020-01-01 Pinato, D. J.; Newsom-Davis, T.; Bower, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions | 1-gen-2022 | Cortellini, A.; Barrichello, A. P. C.; Alessi, J. V.; Ricciuti, B.; Vaz, V. R.; Newsom-Davis, T.; Evans, J. S.; Lamberti, G.; Pecci, F.; Viola, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Awad, M. M.; Pinato, D. J. | |
| A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors | 1-gen-2021 | Khaki, Ali Raza; Li, Ang; Diamantopoulos, Leonidas N; Miller, Natalie J; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Koshkin, Vadim; Park, Joseph; Alva, Ajjai; Bilen, Mehmet A; Stewart, Tyler; Santos, Victor; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yousef; Morales-Barrera, Rafael; Devitt, Michael; Nelson, Ariel; Hoimes, Christopher J; Shreck, Evan; Gartrell, Benjamin A; Sankin, Alex; Tripathi, Abhishek; Zakopoulou, Roubini; Bamias, Aristotelis; Rodriguez-Vida, Alejo; Drakaki, Alexandra; Liu, Sandy; Kumar, Vivek; Lythgoe, Mark P; Pinato, David J; Murgic, Jure; Fröbe, Ana; Joshi, Monika; Isaacsson Velho, Pedro; Hahn, Noah; Alonso Buznego, Lucia; Duran, Ignacio; Moses, Marcus; Barata, Pedro; Galsky, Matthew D; Sonpavde, Guru; Yu, Evan Y; Shankaran, Veena; Lyman, Gary H; Grivas, Petros | |
| A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI) | 1-gen-2012 | Pinato, D. J.; Stebbing, J.; Ishizuka, M.; Khan, S. A.; Wasan, H. S.; North, B. V.; Kubota, K.; Sharma, R. | |
| A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC | 1-gen-2023 | Chen, M.; Lu, H.; Copley, S. J.; Han, Y.; Logan, A.; Viola, P.; Cortellini, A.; Pinato, D. J.; Power, D.; Aboagye, E. O. | |
| A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: The prognostic nutritional index (PNI) | 1-gen-2012 | Pinato, D. J.; North, B. V.; Sharma, R. | |
| A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers | 1-gen-2012 | Libri, V.; Brown, A. P.; Gambarota, G.; Haddad, J.; Shields, G. S.; Dawes, H.; Pinato, D. J.; Hoffman, E.; Elliot, P. J.; Vlasuk, G. P.; Jacobson, E.; Wilkins, M. R.; Matthews, P. M. | |
| Acceleration of interstitial lung disease induced by raltitrexed | 1-gen-2020 | Howlett, S.; Aul, R.; Hill, M.; Pinato, D. J. | |
| Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis | 1-gen-2021 | Gudd, C. L. C.; Au, L.; Triantafyllou, E.; Shum, B.; Liu, T.; Nathwani, R.; Kumar, N.; Mukherjee, S.; Dhar, A.; Woollard, K. J.; Yone, Y.; Pinato, D. J.; Thursz, M. R.; Goldin, R. D.; Gore, M. E.; Larkin, J.; Khamri, W.; Antoniades, C. G.; Turajlic, S.; Possamai, L. A. | |
| Advanced age influences the dynamic changes in circulating C-reactive protein following injury | 1-gen-2013 | Pinato, D. J.; Bains, J.; Irkulla, S.; Pomroy, J.; Ujam, B.; Gaze, D.; Mendall, M. A. | |
| ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma | 1-gen-2021 | Demirtas, Coskun O; D'Alessio, Antonio; Rimassa, Lorenza; Sharma, Rohini; Pinato, David J | |
| Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway | 1-gen-2014 | Trousil, S.; Lee, P.; Pinato, D. J.; Ellis, J. K.; Dina, R.; Aboagye, E. O.; Keun, H. C.; Sharma, R. | |
| An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: Correlation with tumour phenotype and survival outcomes | 1-gen-2014 | Pinato, D. J.; Tan, T. M.; Toussi, S. T. K.; Ramachandran, R.; Martin, N.; Meeran, K.; Ngo, N.; Dina, R.; Sharma, R. | |
| An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials | 1-gen-2014 | Pinato, D. J.; Stavraka, C.; Flynn, M. J.; Forster, M. D.; O'Cathail, S. M.; Seckl, M. J.; Kristeleit, R. S.; Olmos, D.; Turnbull, S. J.; Blagden, S. P. | |
| An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma | 1-gen-2012 | Pinato, D. J.; Sharma, R. | |
| An unexpected cause of pulmonary cannonball lesion | 1-gen-2014 | Pinato, D. J.; Tan, W.; Gately, A. | |
| Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer | 1-gen-2021 | Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Elisa Onesti, Concetta; Harbeck, Nadia; Lüftner, Diana; Rottey, Sylvie; van Dam, Peter A.; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne C. G.; Cortes, Javier; Locci, Mariavittoria; Paris, Ida; Del Mastro, Lucia; De Placido, Sabino; Martín, Miguel; Jerusalem, Guy; Venturini, Sergio; Curigliano, Giuseppe; Generali, Daniele | |
| Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters | 1-gen-2022 | Cortellini, A.; Facchinetti, F.; Derosa, L.; Pinato, D. J. | |
| Antibiotic therapy and outcome from immune-checkpoint inhibitors | 1-gen-2019 | Pinato, D. J.; Gramenitskaya, D.; Altmann, D. M.; Boyton, R. J.; Mullish, B. H.; Marchesi, J. R.; Bower, M. | |
| Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors | 1-gen-2023 | Pinato, David J; Cortellini, Alessio | |
| Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients with Cancer - Reply | 1-gen-2020 | Pinato, D. J.; Newsom-Davis, T.; Bower, M. |